|
|
此文章由 woodywup 原创或转贴，不代表本站立场和观点，版权归 oursteps.com.au 和作者 woodywup 所有！转贴必须注明作者、出处和本声明，并保持内容完整
callcall 发表于 2014-7-9 10:58 
能少扯淡吗......
PBS给钱的话，谁上来给你用Erlotinib或Gefitinib.....
不知道就不要乱说。。。
自己去查查PBS
http://www.health.gov.au/interne ... r2013-dutton026.htm
The Minister for Health, Peter Dutton, today announced new listings on the Pharmaceutical Benefits Scheme (PBS) for medicines to treat diabetes and lung cancer.
The PBS listing of the new medicines or combinations of medicines will apply from 1 February 2014, making these therapies considerably cheaper for Australian patients.
For patients with diabetes, a combination dose of aloglitpin with metformin (sold as Nesina Met®) has now been listed. While the drugs were already listed individually, many patients need to use both medicines at once to treat their condition.
“Making this combination dose available through the PBS will save many patients up to $36.90 whenever they get a script filled because they will be able to buy one medicine instead of two,” Mr Dutton said.
“More than 50,000 people are expected to obtain the combined medicine through the PBS over the next five years. With an average of seven packs each over that period, this represents a considerable saving to people living with diabetes.”
Mr Dutton also announced the PBS listing of erlotinib (sold as Tarceva®) for the treatment of non-small cell lung cancer. The listing provides another treatment option for this type of cancer, following approval in November of PBS listing for gefitinib (sold as Iressa®). |
|
Secret (2013-9-25) braindev 
楼主:MEGAPOXY
发表于 2014-7-9 10:58
